Buy the dip in this MedTech stock says Citi
Tweet Send to a Friend
As per analysts at Citi Research in a note dated Wednesday, the recent decline in Boston Scientific’s stock presents a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


